CEREVEL THERAPEUTICS HLDNG I's ticker is CEREW and the CUSIP is 15678U102. A total of 33 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $4,307,000 | – | 283,332 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 72,466 | $312,000 | 0.11% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 459,215 | $1,979,000 | 0.08% |
| Monashee Investment Management LLC | 99,998 | $431,000 | 0.07% |
| Governors Lane LP | 196,034 | $845,000 | 0.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 166,332 | $702,000 | 0.05% |
| Context Capital Management, LLC | 82,868 | $357,000 | 0.04% |
| EQUITEC SPECIALISTS, LLC | 35,825 | $154,000 | 0.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 166,666 | $718,000 | 0.02% |
| RA Capital Management | 233,333 | $1,006,000 | 0.02% |
| Logos Global Management LP | 33,333 | $144,000 | 0.01% |